A gene therapy designed to replace a missing brain protein restored normal brain activity and improved behavior in a mouse model of fragile X syndrome (FXS), according to a study led by researchers at ...
Researchers have developed an innovative new nanopore sequencing assay to identify carriers of fragile X syndrome (FXS), the leading cause of monogenic autism spectrum disorder and inherited ...
A novel gene therapy restores brain function and behavior in mice, offering hope for treating Fragile X syndrome (FXS) and potentially other genetic neurodevelopmental disorders. A gene therapy ...
UCLA Health researchers have identified a potential drug target for treating fragile X syndrome (FXS), the most common genetic cause of intellectual disability and autism that affects roughly one in 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results